Author

Joshua Hrycaiczuk

Observed names: Hrycaiczuk, J., J Hrycaiczuk, J. Hrycaiczuk

Observed institutions: University of Leeds, Public Health Wales, University Hospitals Bristol and Weston NHS Foundation Trust

OpenAlex ID: A5114092071

Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

2023 · O Abani, A Abbas, et al. · The Lancet Diabetes & Endocrinology · 41

Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial

2024 · Saul N Faust, Richard Haynes, et al. · The Lancet Child & Adolescent Health · 39

Molnupiravir or nirmatrelvir–ritonavir plus usual care versus usual care alone in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

2025 · O Abani, A Abbas, et al. · The Lancet Infectious Diseases · 12

Dimethyl fumarate in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

2024 · RECOVERY Collaborative Group, Peter Sandercock, et al. · Nature Communications · 11

Higher dose corticosteroids in hospitalised COVID-19 patients requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial

2025 · O. Abani, A. Abbas, et al. · EClinicalMedicine · 5

The cost-effectiveness of procalcitonin for guiding antibiotic prescribing in individuals hospitalized with COVID-19: part of the PEACH study

2024 · Edward J D Webb, Daniel Howdon, et al. · Journal of Antimicrobial Chemotherapy · 4

P06 Management challenges and treatment options of difficult-to-treat organisms in patients with complex medical devices: a case of vancomycin-resistant Enterococcus infection in a patient with a left ventricular assist device

2024 · Joshua Hrycaiczuk, Bazga Ali · JAC-Antimicrobial Resistance · 1

Sotrovimab versus usual care in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

2025 · O Abani, A Abbas, et al. · The Lancet Infectious Diseases

Works count: 9

Citation count: 113

H-index: 5

I10-index: 4